Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10314830 Pharmaceutical compositions

Patent 10314830 was granted and assigned to Xspray Microparticles AB on June, 2019 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
‌
Xspray Microparticles AB
0
Date Filed
October 31, 2018
0
Date of Patent
June 11, 2019
0
Patent Applicant
‌
Xspray Microparticles AB
0
Patent Application Number
16176101
0
Patent Citations Received
‌
US Patent 12064428 Kinase inhibitor salts and compositions thereof
0
‌
US Patent 11389450 Amorphous nilotinib microparticles and uses thereof
‌
US Patent 11413290 Amorphous solid dispersions of dasatinib and uses thereof
‌
US Patent 11426391 Pharmaceutical compositions
‌
US Patent 11980619 Pharmaceutical compositions and crushable tablets including amorphous solid dispersions of dasatinib and uses
0
‌
US Patent 11998548 Amorphous nilotinib microparticles and uses thereof
0
‌
US Patent 12016861 Amorphous nilotinib microparticles and uses thereof
0
‌
US Patent 12064430 Kinase inhibitor salts and compositions thereof
0
‌
US Patent 11517562 Pharmaceutical compositions
‌
US Patent 11559485 Orally disintegrating tablet comprising amorphous solid dispersion of nilotinib
•••
Patent Inventor Names
Helene Dérand
0
Martin Malmsten
0
Mustafa Demirbüker
0
Gérald Jesson
0
Magnus Brisander
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
10314830
0
Patent Primary Examiner
‌
Jeffrey T. Palenik
0

Find more entities like US Patent 10314830 Pharmaceutical compositions

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo